Int J Thyroidol.  2023 May;16(1):32-50. 10.11106/ijt.2023.16.1.32.

2023 Korean Thyroid Association Management Guidelines for Patients with Subclinical Hypothyroidism

• Chung HK
• Ku EJ
• Yoo WS
• Kang YE
• Kim KJ
• Kim BH
• Kim TY
• Park YJ
• Ahn CH
• Yoon JH
• Lee EK
• Lee JM
• Jung ED
• Chung JH
• Chung YJ
• Kim WB
• Yi KH
• Kang HC
• Park DJ

• KMID: 2543007
• DOI: http://doi.org/10.11106/ijt.2023.16.1.32

Abstract

Subclinical hypothyroidism (SCH), characterized by elevated serum thyroid-stimulating hormone (TSH) levels and normal free thyroxine levels, usually presents without symptoms, and is often discovered incidentally during routine blood test. The Task Force of the Korean Thyroid Association Committee of Clinical Practice Guidelines has established a guideline to evaluate and manage SCH; the guideline emphasizes the implementation of diagnostic criteria based on the TSH reference range for Koreans and focuses on the proven health benefits of levothyroxine (LT4) treatment. Based on the Korea National Health and Nutrition Examination Survey (2013-2015), serum TSH level of 6.8 mIU/L is considered the reference value for SCH. SCH can be categorized as mild (TSH 6.8-10.0 mIU/L) or severe (TSH ＞10.0 mIU/L), and patients are classified as adults (age ＜70 years) or elderly patients (age ≥70 years) depending on the health effects of LT4 treatment. An initial increase in serum TSH levels should be reassessed with a subsequent measurement, along with the thyroid peroxidase antibody test, preferably 2-3 months after the initial evaluation. Usually, LT4 treatment is not recommended for mild SCH in adults; however, treatment is necessary for severe SCH in patients with underlying coronary artery disease or heart failure and can be considered for coexisting dyslipidemia. LT4 treatment is not recommended for mild or even severe SCH in elderly patients, in general. Patients with SCH who receive LT4 treatment, the LT4 dosage should be personalized, and serum TSH levels should be monitored to ensure optimal LT4 dosage (dosage that is neither excessive nor insufficient). Patients with SCH who do not receive LT4 treatment require periodic follow-up at appropriate testing intervals determined by disease severity. The guideline also provides several educational points applicable in clinical settings.

Keyword

Subclinical hypothyroidism; Thyroid-stimulating hormone; Levothyroxine; Diagnosis; Management

Figure

• 

  Fig. 1 무증상갑상선기능저하증 진료지침 흐름도.

Reference

References

1. Okosieme O, Gilbert J, Abraham P, Boelaert K, Dayan C, Gurnell M, et al. 2016; Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. Clin Endocrinol (Oxf). 84(6):799–808. DOI: 10.1111/cen.12824. PMID: 26010808.

2. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. 2012; Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 22(12):1200–35. DOI: 10.1089/thy.2012.0205. PMID: 22954017.

3. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. 2014; Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 24(12):1670–751. DOI: 10.1089/thy.2014.0028. PMID: 25266247. PMCID: PMC4267409.

4. Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, et al. 2013; 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2(4):215–28. DOI: 10.1159/000356507. PMID: 24783053. PMCID: PMC3923601.

5. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, et al. 2006; Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest. 129(1):174–81. DOI: 10.1378/chest.129.1.174. PMID: 16424429.

6. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. 2000; The Colorado thyroid disease prevalence study. Arch Intern Med. 160(4):526–34. DOI: 10.1001/archinte.160.4.526. PMID: 10695693.

7. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. 2002; Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 87(2):489–99. DOI: 10.1210/jcem.87.2.8182. PMID: 11836274.

8. Jang YY, Kim CY, Hwang TY, Kim KD, Lee CH. 2008; Reference interval of serum thyroid hormones in healthy Korean adults. J Prev Med Public Health. 41(2):128–34. DOI: 10.3961/jpmph.2008.41.2.128. PMID: 18385554.

9. Kim HS, Kim BJ, Oh S, Lee DY, Hwang KR, Jeon HW, et al. 2015; Gestational age-specific cut-off values are needed for diagnosis of subclinical hypothyroidism in early pregnancy. J Korean Med Sci. 30(9):1308–12. DOI: 10.3346/jkms.2015.30.9.1308. PMID: 26339172. PMCID: PMC4553679.

10. Kim WG, Kim WB, Woo G, Kim H, Cho Y, Kim TY, et al. 2017; Thyroid stimulating hormone reference range and prevalence of thyroid dysfunction in the Korean population: Korea national health and nutrition examination survey 2013 to 2015. Endocrinol Metab (Seoul). 32(1):106–14. DOI: 10.3803/EnM.2017.32.1.106. PMID: 28116874. PMCID: PMC5368108.

11. Somwaru LL, Rariy CM, Arnold AM, Cappola AR. 2012; The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab. 97(6):1962–9. DOI: 10.1210/jc.2011-3047. PMID: 22438233. PMCID: PMC3387427.

12. Jeon MJ, Kim WG, Kwon H, Kim M, Park S, Oh HS, et al. 2017; Excessive iodine intake and thyrotropin reference interval: data from the Korean national health and nutrition examination survey. Thyroid. 27(7):967–72. DOI: 10.1089/thy.2017.0078. PMID: 28471294.

13. Park SY, Kim HI, Oh HK, Kim TH, Jang HW, Chung JH, et al. 2018; Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: data from Korean national health and nutrition examination survey IV (2013-2015). PLoS One. 13(2):e0190738. DOI: 10.1371/journal.pone.0190738. PMID: 29390008. PMCID: PMC5794073.

14. Kim M, Kim TY, Kim SH, Lee Y, Park SY, Kim HD, et al. 2015; Reference interval for thyrotropin in a ultrasonography screened Korean population. Korean J Intern Med. 30(3):335–44. DOI: 10.3904/kjim.2015.30.3.335. PMID: 25995664. PMCID: PMC4438288.

15. Moon S, Kong SH, Choi HS, Hwangbo Y, Lee MK, Moon JH, et al. 2018; Relation of subclinical hypothyroidism is associated with cardiovascular events and all-cause mortality in adults with high cardiovascular risk. Am J Cardiol. 122(4):571–7. DOI: 10.1016/j.amjcard.2018.03.371. PMID: 29980273.

16. Gurgel MHC, Ponte CMM, Fontes R, Rocha IV, Batista LAA, Sousa TCS, et al. 2020; Establishment of reference interval for thyroid-stimulating hormone using electrochemiluminescence assay in a healthy adult population from Fortaleza, Brazil. Arch Endocrinol Metab. 64(4):362–8. DOI: 10.20945/2359-3997000000264. PMID: 32725064.

17. Clerico A, Trenti T, Aloe R, Dittadi R, Rizzardi S, Migliardi M, et al. 2018; A multicenter study for the evaluation of the reference interval for TSH in Italy (ELAS TSH Italian Study). Clin Chem Lab Med. 57(2):259–67. DOI: 10.1515/cclm-2018-0541. PMID: 30016276.

18. Chen X, Zheng X, Ding Z, Su Y, Wang S, Cui B, et al. 2020; Relationship of gender and age on thyroid hormone parameters in a large Chinese population. Arch Endocrinol Metab. 64(1):52–8.

19. Kwon H, Kim WG, Jeon MJ, Han M, Kim M, Park S, et al. 2017; Age-specific reference interval of serum TSH levels is high in adolescence in an iodine excess area: Korea national health and nutrition examination survey data. Endocrine. 57(3):445–54. DOI: 10.1007/s12020-017-1375-5. PMID: 28762216.

20. Choi HS, Park YJ, Kim HK, Choi SH, Lim S, Park DJ, et al. 2010; Prevalence of subclinical hypothyroidism in two population based-cohort: Ansung and KLoSHA cohort in Korea. Int J Thyroidol. 3(1):32–40.

21. van de Ven AC, Netea-Maier RT, Smit JW, Kusters R, van der Stappen JW, Pronk-Admiraal CJ, et al. 2015; Thyrotropin versus age relation as an indicator of historical iodine intake. Thyroid. 25(6):629–34. DOI: 10.1089/thy.2014.0574. PMID: 25811973.

22. Loh TP, Ehrenkranz J, Halsall D, Spencer CA, Van Uytfanghe K, Kohrle J. 2023; Clinical interpretation of thyroid tests: considerations for reference intervals. Thyroid. 33(4):404–6. DOI: 10.1089/thy.2023.0096. PMID: 36927102.

23. Roelfsema F, Pereira AM, Adriaanse R, Endert E, Fliers E, Romijn JA, et al. 2010; Thyrotropin secretion in mild and severe primary hypothyroidism is distinguished by amplified burst mass and basal secretion with increased spikiness and approximate entropy. J Clin Endocrinol Metab. 95(2):928–34. DOI: 10.1210/jc.2009-1959. PMID: 19965923.

24. Roelfsema F, Pereira AM, Veldhuis JD, Adriaanse R, Endert E, Fliers E, et al. 2009; Thyrotropin secretion profiles are not different in men and women. J Clin Endocrinol Metab. 94(10):3964–7. DOI: 10.1210/jc.2009-1155. PMID: 19773394.

25. Asvold BO, Bjoro T, Vatten LJ. 2009; Association of serum TSH with high body mass differs between smokers and never-smokers. J Clin Endocrinol Metab. 94(12):5023–7. DOI: 10.1210/jc.2009-1180. PMID: 19846737.

26. Azim S, Nasr C. 2019; Subclinical hypothyroidism: when to treat. Cleve Clin J Med. 86(2):101–10. DOI: 10.3949/ccjm.86a.17053. PMID: 30742580.

27. Livingston EH. 2019; Subclinical hypothyroidism. JAMA. 322(2):180. DOI: 10.1001/jama.2019.9508. PMID: 31287524.

28. Joung JY, Cho YY, Park SM, Kim TH, Kim NK, Sohn SY, et al. 2014; Effect of iodine restriction on thyroid function in subclinical hypothyroid patients in an iodine-replete area: a long period observation in a large-scale cohort. Thyroid. 24(9):1361–8. DOI: 10.1089/thy.2014.0046. PMID: 24892764.

29. Biondi B, Cappola AR, Cooper DS. 2019; Subclinical hypothyroidism: a review. JAMA. 322(2):153–60. DOI: 10.1001/jama.2019.9052. PMID: 31287527.

30. Kim TH, Kim KW, Ahn HY, Choi HS, Won H, Choi Y, et al. 2013; Effect of seasonal changes on the transition between subclinical hypothyroid and euthyroid status. J Clin Endocrinol Metab. 98(8):3420–9. DOI: 10.1210/jc.2013-1607. PMID: 23771919.

31. Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, et al. 2006; Effect of iodine intake on thyroid diseases in China. N Engl J Med. 354(26):2783–93. DOI: 10.1056/NEJMoa054022. PMID: 16807415.

32. World Health Organization. 2013. Urinary iodine concentrations for determining iodine status deficiency in populations. World Health Organization;Geneva:

33. Caldwell KL, Pan Y, Mortensen ME, Makhmudov A, Merrill L, Moye J. 2013; Iodine status in pregnant women in the national children's study and in U.S. women (15-44 years), national health and nutrition examination survey 2005-2010. Thyroid. 23(8):927–37. DOI: 10.1089/thy.2013.0012. PMID: 23488982. PMCID: PMC3752509.

34. van de Ven AC, Netea-Maier RT, Ross HA, van Herwaarden TA, Holewijn S, de Graaf J, et al. 2014; Longitudinal trends in thyroid function in relation to iodine intake: ongoing changes of thyroid function despite adequate current iodine status. Eur J Endocrinol. 170(1):49–54. DOI: 10.1530/EJE-13-0589. PMID: 24114433.

35. Fatourechi V, Klee GG, Grebe SK, Bahn RS, Brennan MD, Hay ID, et al. 2003; Effects of reducing the upper limit of normal TSH values. JAMA. 290(24):3195–6. DOI: 10.1001/jama.290.24.3195-b. PMID: 14693871.

36. Fatourechi V. 2009; Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 84(1):65–71. DOI: 10.4065/84.1.65. PMID: 19121255. PMCID: PMC2664572.

37. Yoo WS, Chung HK. 2021; Subclinical hypothyroidism: prevalence, health impact, and treatment landscape. Endocrinol Metab (Seoul). 36(3):500–13. DOI: 10.3803/EnM.2021.1066. PMID: 34139799. PMCID: PMC8258336.

38. Cooper DS, Biondi B. 2012; Subclinical thyroid disease. Lancet. 379(9821):1142–54. DOI: 10.1016/S0140-6736(11)60276-6. PMID: 22273398.

39. Presotto EM, Rastrelli G, Desideri I, Scotti V, Gunnella S, Pimpinelli N, et al. 2020; Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. J Endocrinol Invest. 43(3):337–45. DOI: 10.1007/s40618-019-01112-8. PMID: 31542865.

40. Mammen JS, Ghazarian SR, Rosen A, Ladenson PW. 2013; Patterns of interferon-alpha-induced thyroid dysfunction vary with ethnicity, sex, smoking status, and pretreatment thyrotropin in an international cohort of patients treated for hepatitis C. Thyroid. 23(9):1151–8. DOI: 10.1089/thy.2012.0565. PMID: 23517287. PMCID: PMC3770239.

41. Bianchi L, Rossi L, Tomao F, Papa A, Zoratto F, Tomao S. 2013; Thyroid dysfunction and tyrosine kinase inhibitors in renal cell carcinoma. Endocr Relat Cancer. 20(5):R233–45. DOI: 10.1530/ERC-13-0201. PMID: 23833016.

42. Kwon O, Shin DY, Lee EJ. 2022; Effect of iodine restriction on short-term changes in thyroid function in patients with subclinical hypothyroidism. J Nutr Health. 55(2):250–62. DOI: 10.4163/jnh.2022.55.2.250.

43. Raza SA, Mahmood N. 2013; Subclinical hypothyroidism: controversies to consensus. Indian J Endocrinol Metab. 17(Suppl 3):S636–42. DOI: 10.4103/2230-8210.123555. PMID: 24910826. PMCID: PMC4046597.

44. Roberts L, McCahon D, Johnson O, Haque MS, Parle J, Hobbs FR. 2018; Stability of thyroid function in older adults: the Birmingham elderly thyroid study. Br J Gen Pract. 68(675):e718–26. DOI: 10.3399/bjgp18X698861. PMID: 30154078. PMCID: PMC6145980.

45. Park WR, Oh TK, Jeon HJ. 2013; Prospective observation of 5-year clinical course of subclinical hypothyroidism in Korean population. J Korean Med Sci. 28(11):1622–6. DOI: 10.3346/jkms.2013.28.11.1622. PMID: 24265525. PMCID: PMC3835504.

46. Delshad H, Mehran L, Tohidi M, Assadi M, Azizi F. 2012; The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I.R. Iran. J Endocrinol Invest. 35(5):516–21.

47. Amouzegar A, Ghaemmaghami Z, Beigy M, Gharibzadeh S, Mehran L, Tohidi M, et al. 2017; Natural course of euthyroidism and clues for early diagnosis of thyroid dysfunction: Tehran thyroid study. Thyroid. 27(5):616–25. DOI: 10.1089/thy.2016.0409. PMID: 28071990.

48. Li X, Zhen D, Zhao M, Liu L, Guan Q, Zhang H, et al. 2017; Natural history of mild subclinical hypothyroidism in a middle-aged and elderly Chinese population: a prospective study. Endocr J. 64(4):437–47. DOI: 10.1507/endocrj.EJ16-0549. PMID: 28302959.

49. Diez JJ, Iglesias P, Burman KD. 2005; Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 90(7):4124–7. DOI: 10.1210/jc.2005-0375. PMID: 15811925.

50. Bekkering GE, Agoritsas T, Lytvyn L, Heen AF, Feller M, Moutzouri E, et al. 2019; Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ. 365:l2006. DOI: 10.1136/bmj.l2006. PMID: 31088853.

51. Ates I, Arikan MF, Altay M, Yilmaz FM, Yilmaz N, Berker D, et al. 2018; The effect of oxidative stress on the progression of Hashimoto's thyroiditis. Arch Physiol Biochem. 124(4):351–6. DOI: 10.1080/13813455.2017.1408660. PMID: 29185364.

52. Rosario PW, Carvalho M, Calsolari MR. 2016; Natural history of subclinical hypothyroidism with TSH </=10 mIU/l: a prospective study. Clin Endocrinol (Oxf). 84(6):878–81. DOI: 10.1111/cen.12939. PMID: 26342200.

53. Lee JM, Ha J, Jo K, Lim Y, Kim MH, Jung CK, et al. 2019; Risk factors for hypothyroidism in euthyroid thyroid nodule patients with lymphocytic thyroiditis on fine needle aspiration cytology. Korean J Intern Med. 34(6):1287–96. DOI: 10.3904/kjim.2017.177. PMID: 29529842. PMCID: PMC6823571.

54. Rotondi M, Leporati P, Rizza MI, Clerici A, Groppelli G, Pallavicini C, et al. 2014; Raised serum TSH in morbid-obese and non-obese patients: effect on the circulating lipid profile. Endocrine. 45(1):92–7. DOI: 10.1007/s12020-013-9928-8. PMID: 23526236.

55. Sang Z, Chen W, Shen J, Tan L, Zhao N, Liu H, et al. 2013; Long-term exposure to excessive iodine from water is associated with thyroid dysfunction in children. J Nutr. 143(12):2038–43. DOI: 10.3945/jn.113.179135. PMID: 24108132.

56. Monzani F, Di Bello V, Caraccio N, Bertini A, Giorgi D, Giusti C, et al. 2001; Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab. 86(3):1110–5. DOI: 10.1210/jcem.86.3.7291. PMID: 11238494.

57. Yazici M, Gorgulu S, Sertbas Y, Erbilen E, Albayrak S, Yildiz O, et al. Effects of thyroxin therapy on cardiac function in patients with subclinical hypothyroidism: index of myocardial performance in the evaluation of left ventricular function. Int J Cardiol. 2004; 95(2-3):135–43. DOI: 10.1016/j.ijcard.2003.05.015. PMID: 15193811.

58. Biondi B. 2012; Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol. 167(5):609–18. DOI: 10.1530/EJE-12-0627. PMID: 22956554.

59. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. 2000; Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med. 132(4):270–8. DOI: 10.7326/0003-4819-132-4-200002150-00004. PMID: 10681281.

60. Monzani F, Caraccio N, Kozakowa M, Dardano A, Vittone F, Virdis A, et al. 2004; Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab. 89(5):2099–106. DOI: 10.1210/jc.2003-031669. PMID: 15126526.

61. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. 2003; Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab. 88(8):3731–7. DOI: 10.1210/jc.2003-030039. PMID: 12915662.

62. Shakoor SA, Aldibbiat A, Ingoe LE, Campbell SC, Sibal L, Shaw J, et al. 2010; Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy. J Clin Endocrinol Metab. 95(1):319–22. DOI: 10.1210/jc.2009-1421. PMID: 19897678.

63. Cabral MD, Teixeira PF, Silva NA, Morais FF, Soares DV, Salles E, et al. 2009; Normal flow-mediated vasodilatation of the brachial artery and carotid artery intima-media thickness in subclinical hypothyroidism. Braz J Med Biol Res. 42(5):426–32. DOI: 10.1590/S0100-879X2009000500005. PMID: 19377791.

64. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, et al. 2010; Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 304(12):1365–74. DOI: 10.1001/jama.2010.1361. PMID: 20858880. PMCID: PMC3923470.

65. Chaker L, Baumgartner C, den Elzen WP, Ikram MA, Blum MR, Collet TH, et al. 2015; Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis. J Clin Endocrinol Metab. 100(6):2181–91. DOI: 10.1210/jc.2015-1438. PMID: 25856213. PMCID: PMC4454799.

66. Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR, et al. 2012; Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation. 126(9):1040–9. DOI: 10.1161/CIRCULATIONAHA.112.096024. PMID: 22821943. PMCID: PMC3884576.

67. Baumgartner C, da Costa BR, Collet TH, Feller M, Floriani C, Bauer DC, et al. 2017; Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation. Circulation. 136(22):2100–16. DOI: 10.1161/CIRCULATIONAHA.117.028753. PMID: 29061566. PMCID: PMC5705446.

68. Moon S, Kim MJ, Yu JM, Yoo HJ, Park YJ. 2018; Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Thyroid. 28(9):1101–10. DOI: 10.1089/thy.2017.0414. PMID: 29978767.

69. Stott DJ, Rodondi N, Kearney PM, Ford I, Westendorp RGJ, Mooijaart SP, et al. 2017; Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 376(26):2534–44. DOI: 10.1056/NEJMoa1603825. PMID: 28402245.

70. Mooijaart SP, Du Puy RS, Stott DJ, Kearney PM, Rodondi N, Westendorp RGJ, et al. 2019; Association between levothyroxine treatment and thyroid-related symptoms among adults aged 80 years and older with subclinical hypothyroidism. JAMA. 322(20):1977–86. DOI: 10.1001/jama.2019.17274. PMID: 31664429. PMCID: PMC6822162.

71. Razvi S, Weaver JU, Butler TJ, Pearce SH. 2012; Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med. 172(10):811–7. DOI: 10.1001/archinternmed.2012.1159. PMID: 22529180.

72. Andersen MN, Olsen AM, Madsen JC, Faber J, Torp-Pedersen C, Gislason GH, et al. 2015; Levothyroxine substitution in patients with subclinical hypothyroidism and the risk of myocardial infarction and mortality. PLoS One. 10(6):e0129793. DOI: 10.1371/journal.pone.0129793. PMID: 26069971. PMCID: PMC4466400.

73. Peng CC, Huang HK, Wu BB, Chang RH, Tu YK, Munir KM. 2021; Association of thyroid hormone therapy with mortality in subclinical hypothyroidism: a systematic review and meta-analysis. J Clin Endocrinol Metab. 106(1):292–303. DOI: 10.1210/clinem/dgaa777. PMID: 33107557.

74. Inoue K, Ritz B, Brent GA, Ebrahimi R, Rhee CM, Leung AM. 2020; Association of subclinical hypothyroidism and cardiovascular disease with mortality. JAMA Netw Open. 3(2):e1920745. DOI: 10.1001/jamanetworkopen.2019.20745. PMID: 32031647.

75. de Moura Souza A, Sichieri R. 2011; Association between serum TSH concentration within the normal range and adiposity. Eur J Endocrinol. 165(1):11–5. DOI: 10.1530/EJE-11-0261. PMID: 21543376.

76. Kitahara CM, Platz EA, Ladenson PW, Mondul AM, Menke A, Berrington de Gonzalez A. 2012; Body fatness and markers of thyroid function among U.S. men and women. PLoS One. 7(4):e34979. DOI: 10.1371/journal.pone.0034979. PMID: 22511976. PMCID: PMC3325258.

77. Nyrnes A, Jorde R, Sundsfjord J. 2006; Serum TSH is positively associated with BMI. Int J Obes (Lond). 30(1):100–5. DOI: 10.1038/sj.ijo.0803112. PMID: 16189501.

78. Fox CS, Pencina MJ, D'Agostino RB, Murabito JM, Seely EW, Pearce EN, et al. 2008; Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med. 168(6):587–92. DOI: 10.1001/archinte.168.6.587. PMID: 18362250.

79. Wolters B, Lass N, Reinehr T. 2013; TSH and free triiodothyronine concentrations are associated with weight loss in a lifestyle intervention and weight regain afterwards in obese children. Eur J Endocrinol. 168(3):323–9. DOI: 10.1530/EJE-12-0981. PMID: 23211576.

80. Reinehr T, de Sousa G, Andler W. 2006; Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab. 91(8):3088–91. DOI: 10.1210/jc.2006-0095. PMID: 16684827.

81. Dall'Asta C, Paganelli M, Morabito A, Vedani P, Barbieri M, Paolisso G, et al. 2010; Weight loss through gastric banding: effects on TSH and thyroid hormones in obese subjects with normal thyroid function. Obesity (Silver Spring). 18(4):854–7. DOI: 10.1038/oby.2009.320. PMID: 19834461.

82. Chikunguwo S, Brethauer S, Nirujogi V, Pitt T, Udomsawaengsup S, Chand B, et al. 2007; Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis. 3(6):631–5. discussion 5–6. DOI: 10.1016/j.soard.2007.07.011. PMID: 18023816.

83. Ding X, Zhao Y, Zhu CY, Wu LP, Wang Y, Peng ZY, et al. 2021; The association between subclinical hypothyroidism and metabolic syndrome: an update meta-analysis of observational studies. Endocr J. 68(9):1043–56. DOI: 10.1507/endocrj.EJ20-0796. PMID: 33883332.

84. Boekholdt SM, Titan SM, Wiersinga WM, Chatterjee K, Basart DC, Luben R, et al. 2010; Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf). 72(3):404–10. DOI: 10.1111/j.1365-2265.2009.03640.x. PMID: 19486022.

85. Liu XL, He S, Zhang SF, Wang J, Sun XF, Gong CM, et al. 2014; Alteration of lipid profile in subclinical hypothyroidism: a meta-analysis. Med Sci Monit. 20:1432–41. DOI: 10.12659/MSM.891163. PMID: 25124461. PMCID: PMC4144946.

86. Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, et al. 2001; TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 86(10):4860–6. DOI: 10.1210/jcem.86.10.7973. PMID: 11600554.

87. Caraccio N, Ferrannini E, Monzani F. 2002; Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab. 87(4):1533–8. DOI: 10.1210/jcem.87.4.8378. PMID: 11932277.

88. Teixeira PF, Reuters VS, Ferreira MM, Almeida CP, Reis FA, Melo BA, et al. 2008; Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. Horm Metab Res. 40(1):50–5. DOI: 10.1055/s-2007-993216. PMID: 18085502.

89. Li X, Wang Y, Guan Q, Zhao J, Gao L. 2017; The lipid-lowering effect of levothyroxine in patients with subclinical hypothyroidism: a systematic review and meta-analysis of randomized controlled trials. Clin Endocrinol (Oxf). 87(1):1–9. DOI: 10.1111/cen.13338. PMID: 28342184.

90. Abreu IM, Lau E, de Sousa Pinto B, Carvalho D. 2017; Subclinical hypothyroidism: to treat or not to treat, that is the question! A systematic review with meta-analysis on lipid profile. Endocr Connect. 6(3):188–99. DOI: 10.1530/EC-17-0028. PMID: 28249936. PMCID: PMC5428911.

91. Bode H, Ivens B, Bschor T, Schwarzer G, Henssler J, Baethge C. 2021; Association of hypothyroidism and clinical depression: a systematic review and meta-analysis. JAMA Psychiatry. 78(12):1375–83. DOI: 10.1001/jamapsychiatry.2021.2506. PMID: 34524390. PMCID: PMC8444067.

92. Loh HH, Lim LL, Yee A, Loh HS. 2019; Association between subclinical hypothyroidism and depression: an updated systematic review and meta-analysis. BMC Psychiatry. 19(1):12. DOI: 10.1186/s12888-018-2006-2. PMID: 30621645. PMCID: PMC6325749.

93. Zhao T, Chen BM, Zhao XM, Shan ZY. 2018; Subclinical hypothyroidism and depression: a meta-analysis. Transl Psychiatry. 8(1):239. DOI: 10.1038/s41398-018-0283-7. PMID: 30375372. PMCID: PMC6207556.

94. Feller M, Snel M, Moutzouri E, Bauer DC, de Montmollin M, Aujesky D, et al. 2018; Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis. JAMA. 320(13):1349–59. DOI: 10.1001/jama.2018.13770. PMID: 30285179. PMCID: PMC6233842.

95. Parsaik AK, Singh B, Roberts RO, Pankratz S, Edwards KK, Geda YE, et al. 2014; Hypothyroidism and risk of mild cognitive impairment in elderly persons: a population-based study. JAMA Neurol. 71(2):201–7. DOI: 10.1001/jamaneurol.2013.5402. PMID: 24378475. PMCID: PMC4136444.

96. Rieben C, Segna D, da Costa BR, Collet TH, Chaker L, Aubert CE, et al. 2016; Subclinical thyroid dysfunction and the risk of cognitive decline: a meta-analysis of prospective cohort studies. J Clin Endocrinol Metab. 101(12):4945–54. DOI: 10.1210/jc.2016-2129. PMID: 27689250. PMCID: PMC6287525.

97. van Vliet NA, van Heemst D, Almeida OP, Asvold BO, Aubert CE, Bae JB, et al. 2021; Association of thyroid dysfunction with cognitive function: an individual participant data analysis. JAMA Intern Med. 181(11):1440–50. DOI: 10.1001/jamainternmed.2021.5078. PMID: 34491268. PMCID: PMC8424529.

98. Pasqualetti G, Pagano G, Rengo G, Ferrara N, Monzani F. 2015; Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis. J Clin Endocrinol Metab. 100(11):4240–8. DOI: 10.1210/jc.2015-2046. PMID: 26305618.

99. Recker S, Voigtlander R, Viehmann A, Dunschen K, Kerp H, Frank-Raue K, et al. 2019; Thyroid related quality of life in elderly with subclinical hypothyroidism and improvement on levothyroxine is distinct from that in young patients (TSAGE). Horm Metab Res. 51(9):568–74. DOI: 10.1055/a-0897-8785. PMID: 31505703.

100. Carlé A, Karmisholt JS, Knudsen N, Perrild H, Thuesen BH, Ovesen L, et al. 2021; Does subclinical hypothyroidism add any symptoms? Evidence from a Danish population-based study. Am J Med. 134(9):1115–26 e1. DOI: 10.1016/j.amjmed.2021.03.009. PMID: 33872585.

101. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. 2007; The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 92(5):1715–23. DOI: 10.1210/jc.2006-1869. PMID: 17299073.

102. Okosieme OE, Belludi G, Spittle K, Kadiyala R, Richards J. 2011; Adequacy of thyroid hormone replacement in a general population. QJM. 104(5):395–401. DOI: 10.1093/qjmed/hcq222. PMID: 21109503.

103. Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. 2010; Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 95(1):186–93. DOI: 10.1210/jc.2009-1625. PMID: 19906785.

104. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG. 2006; Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab. 91(1):145–53. DOI: 10.1210/jc.2005-1775. PMID: 16263815.

105. Parle J, Roberts L, Wilson S, Pattison H, Roalfe A, Haque MS, et al. 2010; A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham elderly thyroid study. J Clin Endocrinol Metab. 95(8):3623–32. DOI: 10.1210/jc.2009-2571. PMID: 20501682.

106. Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy W, Cook D, et al. 1996; Does treatment with l-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med. 11(12):744–9. DOI: 10.1007/BF02598988. PMID: 9016421.

107. Burgos N, Toloza FJK, Singh Ospina NM, Brito JP, Salloum RG, Hassett LC, et al. 2021; Clinical outcomes after discontinuation of thyroid hormone replacement: a systematic review and meta-analysis. Thyroid. 31(5):740–51. DOI: 10.1089/thy.2020.0679. PMID: 33161885. PMCID: PMC8110016.

108. Radetti G, Salerno M, Guzzetti C, Cappa M, Corrias A, Cassio A, et al. 2017; Thyroid function in children and adolescents with Hashimoto's thyroiditis after l-thyroxine discontinuation. Endocr Connect. 6(4):206–12. DOI: 10.1530/EC-17-0023. PMID: 28348002. PMCID: PMC5434746.

109. Livadas S, Bothou C, Androulakis I, Boniakos A, Angelopoulos N, Duntas L. Levothyroxine replacement therapy and overuse: a timely diagnostic approach. Thyroid. 2018; [Online ahead of print]. DOI: 10.1089/thy.2018.0014. PMID: 30351232.

110. Rosario PW, Calsolari MR. 2016; Levothyroxine therapy in the subclinical hypothyroidism: a lifelong therapy? A long-term study. Clin Endocrinol (Oxf). 85(5):819–20. DOI: 10.1111/cen.13174. PMID: 27515774.

111. Bach-Huynh TG, Nayak B, Loh J, Soldin S, Jonklaas J. 2009; Timing of levothyroxine administration affects serum thyrotropin concentration. J Clin Endocrinol Metab. 94(10):3905–12. DOI: 10.1210/jc.2009-0860. PMID: 19584184. PMCID: PMC2758731.

112. Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JG, Berghout A. 2010; Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 170(22):1996–2003. DOI: 10.1001/archinternmed.2010.436. PMID: 21149757.

113. Benvenga S, Bartolone L, Pappalardo MA, Russo A, Lapa D, Giorgianni G, et al. 2008; Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 18(3):293–301. DOI: 10.1089/thy.2007.0222. PMID: 18341376.

114. Bell DS, Ovalle F. 2001; Use of soy protein supplement and resultant need for increased dose of levothyroxine. Endocr Pract. 7(3):193–4. DOI: 10.4158/EP.7.3.193. PMID: 11421567.

115. Liwanpo L, Hershman JM. 2009; Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 23(6):781–92. DOI: 10.1016/j.beem.2009.06.006. PMID: 19942153.

116. Gkotsina M, Michalaki M, Mamali I, Markantes G, Sakellaropoulos GC, Kalfarentzos F, et al. 2013; Improved levothyroxine pharmacokinetics after bariatric surgery. Thyroid. 23(4):414–9. DOI: 10.1089/thy.2011.0526. PMID: 23110329.

117. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L. 2006; Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 91(7):2592–9. DOI: 10.1210/jc.2006-0448. PMID: 16670166.

118. Kim JY, Moon SJ, Kim KR, Sohn CY, Oh JJ. 1998; Dietary iodine intake and urinary iodine excretion in normal Korean adults. Yonsei Med J. 39(4):355–62. DOI: 10.3349/ymj.1998.39.4.355. PMID: 9752802.

119. Yi KH, Ahn HY, Kim JH, Park SY, Yoo WS, Jung KY, et al. 2023 revised Korean thyroid association guidelines for the diagnosis and management of thyroid disease during pregnancy and postpartum. Int J Thyroidol. 2023; 16(1):51–88. DOI: 10.11106/ijt.2023.16.1.51.